• Palbociclib (PD0332991): Advanced Workflows in Cancer Modeli

  2026-06-12

  Palbociclib (PD0332991) is redefining cell cycle research by enabling robust G0/G1 arrest and apoptosis induction in complex tumor models. This article details protocol enhancements, assembloid-specific workflows, and troubleshooting strategies that unlock the full potential of this selective CDK4/6 inhibitor from APExBIO.

• ATP Solution Enables High-Fidelity Kinase & mRNA Assays

  2026-06-12

  APExBIO’s ATP Solution (100 mM) sets a new standard for sensitive enzymatic assays—empowering translational workflows from kinase profiling to mRNA therapeutics. Discover protocol refinements and troubleshooting tips that unlock reproducibility in advanced molecular biology.

• Silymarin and Silybin A: Precision Tools for Liver Research

  2026-06-11

  Silybin A, the bioactive core of Silymarin, delivers unmatched reliability for liver disease, metabolic, and cancer biology research. Leveraging high-purity Silybin A from APExBIO streamlines assay reproducibility and enables advanced mechanistic studies that outpace generic silibinin products.

• L-Glutathione Reduced: Antioxidant Mechanisms & Research Uti

  2026-06-11

  L-Glutathione Reduced (B7775) is a key endogenous antioxidant tripeptide widely used as a substrate in redox and GST-affinity studies. Its thiol-based redox cycling underpins its role as a biomarker in oxidative stress and cancer metabolism research. APExBIO provides validated supply and stability data for reproducible results.

• Salinomycin: Polyether Ionophore Antibiotic in HCC Workflows

  2026-06-10

  Salinomycin is redefining hepatocellular carcinoma research as a polyether ionophore antibiotic with precise inhibition of the Wnt/β-catenin pathway and ABC transporters. Grounded in recent advances in in vitro drug response evaluation, this article delivers workflow enhancements, troubleshooting, and comparative insights for elevating cancer cell apoptosis assays.

• Tp47-Induced Macrophage Senescence via PKM2 Metabolic Reprog

  2026-06-10

  The referenced study uncovers how Treponema pallidum protein Tp47 drives inflammatory senescence in macrophages through PKM2-mediated metabolic changes. This mechanistic insight not only clarifies pathogen evasion in syphilis but also suggests new targets for modulating immune senescence in infectious disease.

• DRD4 Drives Chemo-Resistance via PI3K/Akt/β-Catenin in Liver

  2026-06-09

  The referenced study reveals that dopamine receptor D4 (DRD4) critically enhances chemo-resistance and cancer stem cell-like properties in hepatocellular carcinoma by activating the PI3K/Akt/β-catenin axis. This mechanistic insight suggests novel targets to overcome drug resistance and improve therapeutic outcomes in liver cancer.

• Prolonging Corneal Epithelial Cell Proliferation with 6C Med

  2026-06-09

  The reference study developed a serum-free 6C medium that sustains mouse corneal epithelial cell (mCEC) proliferation both in vitro and in vivo. By integrating six targeted pathway modulators, including IWP-2, this method suppresses unwanted epithelial-mesenchymal transdifferentiation and enhances the yield of transplantable epithelial sheets—potentially advancing regenerative approaches for corneal repair.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-08

  This study provides a detailed analysis of how male and female mice differ in their blood pressure response to chronic angiotensin II infusion, revealing distinct roles for sex hormones in hypertension development. The findings have direct implications for experimental design in preclinical vascular research and highlight the value of mechanistic NO donor tools for dissecting sex-specific cardiovascular pathways.

• Sulfur Input Delays Soybean Nodule Senescence via RNS Regula

  2026-06-08

  A recent study uncovers the pivotal role of sulfur transport into the symbiosome in delaying nodule senescence in soybean by sustaining glutathione levels and controlling reactive nitrogen species. This mechanistic insight offers new strategies for enhancing symbiotic nitrogen fixation and legume productivity through targeted nutrient and genetic interventions.

• Metformin Hydrochloride: Applied Protocols in Immunometaboli

  2026-06-07

  Unlock the translational power of Metformin Hydrochloride (Metformin HCl) in immune-metabolic research with workflow-driven guidance. Explore cutting-edge protocols, troubleshooting strategies, and insight into how metabolic modulation redefines cytokine analysis and disease modeling.

• Moxidectin Enhances Polyene Antifungals Against Oral Candidi

  2026-06-06

  A 2024 study demonstrates that moxidectin, a macrocyclic lactone anthelmintic, activates ergosterol biosynthesis in Candida albicans, thereby synergizing with polyene antifungals to combat oral candidiasis. This mechanistic advance suggests new avenues for overcoming antifungal resistance and refining combination therapies.

• Moxidectin Synergizes with Polyenes via Ergosterol Upregulat

  2026-06-05

  A 2024 study demonstrates that moxidectin, a macrocyclic lactone anthelmintic, elevates ergosterol biosynthesis in Candida albicans, thereby enhancing the antifungal activity of polyenes such as amphotericin B and nystatin. These findings reveal a novel cross-domain mechanism, suggesting new combination strategies for combating oral candidiasis, especially in the context of drug resistance and toxicity.

• VX-702 and the Conformational Control of p38α MAPK: A New Er

  2026-06-05

  Discover how VX-702, a potent p38α MAPK inhibitor, uniquely leverages conformational dynamics to advance inflammation and cardiovascular research. This article explores the latest mechanistic insights and guides researchers in optimizing experimental outcomes.

• Cardiogreen (Indocyanine Green): Applied Protocols and Innov

  2026-06-04

  Cardiogreen (Indocyanine Green) stands out for its dual utility in high-resolution vascular diagnostics and as a photosensitizer in advanced photodynamic therapy. This article translates cutting-edge research into actionable workflows, highlights troubleshooting strategies, and demonstrates how APExBIO’s high-purity Cardiogreen accelerates translational outcomes in both cardiovascular and oncology labs.

453 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page